News
Vivani and Okava initiated their collaboration in 2019, with a focus on developing OKV-119 for cardiometabolic conditions in cats. OKV-119 leverages Vivani’s proprietary NanoPortal™ technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback